Lu-AF28996
- Generic Name
- Lu-AF28996
A Study Investigating the Movement of Lu AF28996 Into, Through, and Out of the Body of Healthy Men
- First Posted Date
- 2024-03-29
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 8
- Registration Number
- NCT06337110
- Locations
- 🇬🇧
Fortrea Clinical Research Unit Ltd, Leeds, United Kingdom
A Trial Investigating Lu AF28996 in Healthy Adult Participants
Phase 1
Completed
- Conditions
- Healthy Participants
- Interventions
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 22
- Registration Number
- NCT06277609
- Locations
- 🇺🇸
Covance Dallas CRU, Dallas, Texas, United States
A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD)
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2023-12-11
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 6
- Registration Number
- NCT06004180
- Locations
- 🇯🇵
Ehime University Hospital, Ehime, Japan
Lu AF28996 in Participants With Parkinson's Disease (PD)
- First Posted Date
- 2020-03-02
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 63
- Registration Number
- NCT04291859
- Locations
- 🇺🇸
Georgetown University, Washington, District of Columbia, United States
🇺🇸Neurology Consultants of Nebraska, Omaha, Nebraska, United States
🇪🇸Hospital Vall d´Hebron, Barcelona, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath